nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—DRD2—obesity	0.221	0.564	CbGaD
Molindone—HTR2A—obesity	0.171	0.436	CbGaD
Molindone—ADRA2A—Benzphetamine—obesity	0.12	0.363	CbGbCtD
Molindone—ADRA2A—Phenylpropanolamine—obesity	0.115	0.346	CbGbCtD
Molindone—ADRA2A—Methamphetamine—obesity	0.0963	0.29	CbGbCtD
Molindone—HTR7—sympathetic nervous system—obesity	0.00542	0.126	CbGeAlD
Molindone—HTR7—vagus nerve—obesity	0.00525	0.122	CbGeAlD
Molindone—HTR7—autonomic nervous system—obesity	0.00364	0.0848	CbGeAlD
Molindone—HTR2A—sympathetic nervous system—obesity	0.00338	0.0787	CbGeAlD
Molindone—HTR2A—vagus nerve—obesity	0.00327	0.0762	CbGeAlD
Molindone—Akinesia—Bupropion—obesity	0.00323	0.0276	CcSEcCtD
Molindone—Galactorrhoea—Cimetidine—obesity	0.00288	0.0246	CcSEcCtD
Molindone—Euphoric mood—Methamphetamine—obesity	0.0027	0.0231	CcSEcCtD
Molindone—Dyskinesia—Phenylpropanolamine—obesity	0.00251	0.0215	CcSEcCtD
Molindone—HTR2A—autonomic nervous system—obesity	0.00227	0.0529	CbGeAlD
Molindone—Dyskinesia—Diethylpropion—obesity	0.00209	0.0179	CcSEcCtD
Molindone—Akinesia—Topiramate—obesity	0.00206	0.0176	CcSEcCtD
Molindone—Euphoric mood—Phenylpropanolamine—obesity	0.00203	0.0173	CcSEcCtD
Molindone—Euphoric mood—Phentermine—obesity	0.00194	0.0166	CcSEcCtD
Molindone—Akathisia—Sibutramine—obesity	0.0018	0.0154	CcSEcCtD
Molindone—Gynaecomastia—Diethylpropion—obesity	0.00176	0.015	CcSEcCtD
Molindone—Muscle rigidity—Bupropion—obesity	0.0017	0.0145	CcSEcCtD
Molindone—Euphoric mood—Diethylpropion—obesity	0.00169	0.0144	CcSEcCtD
Molindone—Gynaecomastia—Cimetidine—obesity	0.00167	0.0143	CcSEcCtD
Molindone—Libido increased—Sibutramine—obesity	0.00164	0.014	CcSEcCtD
Molindone—Urinary retention—Phenylpropanolamine—obesity	0.00163	0.0139	CcSEcCtD
Molindone—HTR1A—hindbrain—obesity	0.00161	0.0374	CbGeAlD
Molindone—Akathisia—Bupropion—obesity	0.00157	0.0134	CcSEcCtD
Molindone—HTR7—hindbrain—obesity	0.00153	0.0357	CbGeAlD
Molindone—DRD2—hindbrain—obesity	0.00145	0.0338	CbGeAlD
Molindone—Libido increased—Bupropion—obesity	0.00143	0.0122	CcSEcCtD
Molindone—Drowsiness—Phenylpropanolamine—obesity	0.00132	0.0113	CcSEcCtD
Molindone—Urinary retention—Cimetidine—obesity	0.00129	0.011	CcSEcCtD
Molindone—Tremor—Methamphetamine—obesity	0.00129	0.011	CcSEcCtD
Molindone—Agitation—Methamphetamine—obesity	0.00126	0.0108	CcSEcCtD
Molindone—Tremor—Benzphetamine—obesity	0.00124	0.0106	CcSEcCtD
Molindone—Agitation—Benzphetamine—obesity	0.00122	0.0104	CcSEcCtD
Molindone—Amenorrhoea—Orlistat—obesity	0.00117	0.01	CcSEcCtD
Molindone—Extrapyramidal disorder—Bupropion—obesity	0.00116	0.00988	CcSEcCtD
Molindone—Vision blurred—Phendimetrazine—obesity	0.00114	0.00973	CcSEcCtD
Molindone—Amenorrhoea—Sibutramine—obesity	0.00114	0.00971	CcSEcCtD
Molindone—Tremor—Phendimetrazine—obesity	0.00113	0.00967	CcSEcCtD
Molindone—Agitation—Phendimetrazine—obesity	0.00111	0.00948	CcSEcCtD
Molindone—Drowsiness—Diethylpropion—obesity	0.0011	0.00939	CcSEcCtD
Molindone—Tachycardia—Methamphetamine—obesity	0.00109	0.00935	CcSEcCtD
Molindone—Leukocytosis—Sibutramine—obesity	0.00106	0.00908	CcSEcCtD
Molindone—Tachycardia—Benzphetamine—obesity	0.00105	0.00902	CcSEcCtD
Molindone—Drowsiness—Cimetidine—obesity	0.00105	0.00894	CcSEcCtD
Molindone—Amenorrhoea—Bupropion—obesity	0.00099	0.00847	CcSEcCtD
Molindone—Vision blurred—Phenylpropanolamine—obesity	0.000972	0.00831	CcSEcCtD
Molindone—Salivary hypersecretion—Sibutramine—obesity	0.000969	0.00829	CcSEcCtD
Molindone—Tremor—Phenylpropanolamine—obesity	0.000966	0.00826	CcSEcCtD
Molindone—Tachycardia—Phendimetrazine—obesity	0.000961	0.00822	CcSEcCtD
Molindone—Constipation—Methamphetamine—obesity	0.000958	0.00819	CcSEcCtD
Molindone—HTR2A—hindbrain—obesity	0.000957	0.0223	CbGeAlD
Molindone—Agitation—Phenylpropanolamine—obesity	0.000947	0.0081	CcSEcCtD
Molindone—HTR7—respiratory system—obesity	0.000937	0.0218	CbGeAlD
Molindone—Dyskinesia—Bupropion—obesity	0.000926	0.00792	CcSEcCtD
Molindone—Leukocytosis—Bupropion—obesity	0.000926	0.00792	CcSEcCtD
Molindone—Tremor—Phentermine—obesity	0.000924	0.0079	CcSEcCtD
Molindone—Libido increased—Topiramate—obesity	0.000911	0.00779	CcSEcCtD
Molindone—Agitation—Phentermine—obesity	0.000907	0.00775	CcSEcCtD
Molindone—DRD2—respiratory system—obesity	0.000886	0.0206	CbGeAlD
Molindone—Hyperkinesia—Sibutramine—obesity	0.000871	0.00744	CcSEcCtD
Molindone—Euphoric mood—Sibutramine—obesity	0.000858	0.00733	CcSEcCtD
Molindone—Salivary hypersecretion—Bupropion—obesity	0.000845	0.00723	CcSEcCtD
Molindone—Constipation—Phendimetrazine—obesity	0.000842	0.0072	CcSEcCtD
Molindone—CHRM1—cardiovascular system—obesity	0.000842	0.0196	CbGeAlD
Molindone—Dry mouth—Phentermine—obesity	0.000821	0.00702	CcSEcCtD
Molindone—Tachycardia—Phenylpropanolamine—obesity	0.000821	0.00702	CcSEcCtD
Molindone—Vision blurred—Diethylpropion—obesity	0.000809	0.00692	CcSEcCtD
Molindone—Tremor—Diethylpropion—obesity	0.000804	0.00688	CcSEcCtD
Molindone—Agitation—Diethylpropion—obesity	0.000789	0.00674	CcSEcCtD
Molindone—Hypotension—Phenylpropanolamine—obesity	0.000786	0.00672	CcSEcCtD
Molindone—Tachycardia—Phentermine—obesity	0.000786	0.00672	CcSEcCtD
Molindone—Gynaecomastia—Bupropion—obesity	0.000779	0.00666	CcSEcCtD
Molindone—Leukopenia—Diethylpropion—obesity	0.000768	0.00657	CcSEcCtD
Molindone—Hyperkinesia—Bupropion—obesity	0.000759	0.00649	CcSEcCtD
Molindone—HTR1A—cardiovascular system—obesity	0.000751	0.0175	CbGeAlD
Molindone—Agitation—Cimetidine—obesity	0.000751	0.00642	CcSEcCtD
Molindone—Dyspnoea—Phenylpropanolamine—obesity	0.00075	0.00641	CcSEcCtD
Molindone—Somnolence—Phenylpropanolamine—obesity	0.000748	0.0064	CcSEcCtD
Molindone—Euphoric mood—Bupropion—obesity	0.000748	0.00639	CcSEcCtD
Molindone—Leukopenia—Cimetidine—obesity	0.000731	0.00625	CcSEcCtD
Molindone—ADRA2A—islet of Langerhans—obesity	0.000728	0.017	CbGeAlD
Molindone—Constipation—Phenylpropanolamine—obesity	0.00072	0.00615	CcSEcCtD
Molindone—Disturbance in sexual arousal—Sibutramine—obesity	0.000719	0.00615	CcSEcCtD
Molindone—HTR7—cardiovascular system—obesity	0.000718	0.0167	CbGeAlD
Molindone—Dry mouth—Diethylpropion—obesity	0.000715	0.00611	CcSEcCtD
Molindone—Urinary retention—Sibutramine—obesity	0.000689	0.00589	CcSEcCtD
Molindone—Constipation—Phentermine—obesity	0.000689	0.00589	CcSEcCtD
Molindone—Tachycardia—Diethylpropion—obesity	0.000684	0.00585	CcSEcCtD
Molindone—Tachycardia—Cimetidine—obesity	0.000651	0.00556	CcSEcCtD
Molindone—Nausea—Benzphetamine—obesity	0.000642	0.00549	CcSEcCtD
Molindone—Amenorrhoea—Topiramate—obesity	0.000631	0.00539	CcSEcCtD
Molindone—Disturbance in sexual arousal—Bupropion—obesity	0.000627	0.00536	CcSEcCtD
Molindone—Dysphagia—Sibutramine—obesity	0.000626	0.00535	CcSEcCtD
Molindone—Dyspnoea—Diethylpropion—obesity	0.000625	0.00534	CcSEcCtD
Molindone—Somnolence—Diethylpropion—obesity	0.000623	0.00532	CcSEcCtD
Molindone—DRD2—pituitary gland—obesity	0.000601	0.014	CbGeAlD
Molindone—Urinary retention—Bupropion—obesity	0.000601	0.00514	CcSEcCtD
Molindone—Constipation—Diethylpropion—obesity	0.000599	0.00512	CcSEcCtD
Molindone—HTR7—digestive system—obesity	0.000596	0.0139	CbGeAlD
Molindone—HTR1A—adrenal gland—obesity	0.000594	0.0138	CbGeAlD
Molindone—Somnolence—Cimetidine—obesity	0.000593	0.00507	CcSEcCtD
Molindone—Dyskinesia—Topiramate—obesity	0.00059	0.00504	CcSEcCtD
Molindone—Nausea—Phendimetrazine—obesity	0.000585	0.005	CcSEcCtD
Molindone—HTR2A—respiratory system—obesity	0.000584	0.0136	CbGeAlD
Molindone—CHRM1—endocrine gland—obesity	0.000578	0.0135	CbGeAlD
Molindone—Constipation—Cimetidine—obesity	0.00057	0.00487	CcSEcCtD
Molindone—Weight increased—Sibutramine—obesity	0.00057	0.00487	CcSEcCtD
Molindone—HTR7—adrenal gland—obesity	0.000568	0.0132	CbGeAlD
Molindone—Dysphagia—Bupropion—obesity	0.000546	0.00467	CcSEcCtD
Molindone—Salivary hypersecretion—Topiramate—obesity	0.000538	0.0046	CcSEcCtD
Molindone—Rash—Phenylpropanolamine—obesity	0.000531	0.00454	CcSEcCtD
Molindone—Dermatitis—Phenylpropanolamine—obesity	0.00053	0.00453	CcSEcCtD
Molindone—HTR1A—endocrine gland—obesity	0.000515	0.012	CbGeAlD
Molindone—Rash—Phentermine—obesity	0.000508	0.00434	CcSEcCtD
Molindone—Dermatitis—Phentermine—obesity	0.000507	0.00434	CcSEcCtD
Molindone—Nausea—Phenylpropanolamine—obesity	0.0005	0.00427	CcSEcCtD
Molindone—Weight increased—Bupropion—obesity	0.000497	0.00425	CcSEcCtD
Molindone—Weight decreased—Bupropion—obesity	0.000494	0.00422	CcSEcCtD
Molindone—HTR7—endocrine gland—obesity	0.000492	0.0115	CbGeAlD
Molindone—Hyperkinesia—Topiramate—obesity	0.000484	0.00413	CcSEcCtD
Molindone—Nausea—Phentermine—obesity	0.000478	0.00409	CcSEcCtD
Molindone—Euphoric mood—Topiramate—obesity	0.000476	0.00407	CcSEcCtD
Molindone—ADRA2A—pituitary gland—obesity	0.000466	0.0109	CbGeAlD
Molindone—DRD2—endocrine gland—obesity	0.000465	0.0108	CbGeAlD
Molindone—ADRA2A—adipose tissue—obesity	0.000464	0.0108	CbGeAlD
Molindone—HTR2A—cardiovascular system—obesity	0.000447	0.0104	CbGeAlD
Molindone—HTR7—liver—obesity	0.000444	0.0103	CbGeAlD
Molindone—Rash—Diethylpropion—obesity	0.000442	0.00378	CcSEcCtD
Molindone—Dermatitis—Diethylpropion—obesity	0.000441	0.00377	CcSEcCtD
Molindone—Muscle spasms—Orlistat—obesity	0.000433	0.00371	CcSEcCtD
Molindone—Vision blurred—Orlistat—obesity	0.000425	0.00363	CcSEcCtD
Molindone—Rash—Cimetidine—obesity	0.00042	0.00359	CcSEcCtD
Molindone—Dermatitis—Cimetidine—obesity	0.00042	0.00359	CcSEcCtD
Molindone—Muscle spasms—Sibutramine—obesity	0.00042	0.00359	CcSEcCtD
Molindone—ADRA2A—adrenal gland—obesity	0.000416	0.0097	CbGeAlD
Molindone—Nausea—Diethylpropion—obesity	0.000416	0.00356	CcSEcCtD
Molindone—Vision blurred—Sibutramine—obesity	0.000411	0.00352	CcSEcCtD
Molindone—Tremor—Sibutramine—obesity	0.000409	0.0035	CcSEcCtD
Molindone—Agitation—Sibutramine—obesity	0.000401	0.00343	CcSEcCtD
Molindone—Disturbance in sexual arousal—Topiramate—obesity	0.000399	0.00341	CcSEcCtD
Molindone—HTR2A—pituitary gland—obesity	0.000396	0.00923	CbGeAlD
Molindone—Nausea—Cimetidine—obesity	0.000396	0.00339	CcSEcCtD
Molindone—Leukopenia—Sibutramine—obesity	0.000391	0.00334	CcSEcCtD
Molindone—Urinary retention—Topiramate—obesity	0.000383	0.00327	CcSEcCtD
Molindone—Dry mouth—Orlistat—obesity	0.000375	0.00321	CcSEcCtD
Molindone—HTR2A—digestive system—obesity	0.000371	0.00865	CbGeAlD
Molindone—Muscle spasms—Bupropion—obesity	0.000366	0.00313	CcSEcCtD
Molindone—Dry mouth—Sibutramine—obesity	0.000363	0.00311	CcSEcCtD
Molindone—ADRA2A—endocrine gland—obesity	0.000361	0.00841	CbGeAlD
Molindone—Vision blurred—Bupropion—obesity	0.000359	0.00307	CcSEcCtD
Molindone—Tremor—Bupropion—obesity	0.000356	0.00305	CcSEcCtD
Molindone—HTR2A—adrenal gland—obesity	0.000354	0.00825	CbGeAlD
Molindone—Agitation—Bupropion—obesity	0.00035	0.00299	CcSEcCtD
Molindone—Dysphagia—Topiramate—obesity	0.000348	0.00297	CcSEcCtD
Molindone—Tachycardia—Sibutramine—obesity	0.000348	0.00297	CcSEcCtD
Molindone—Leukopenia—Bupropion—obesity	0.000341	0.00291	CcSEcCtD
Molindone—Hypotension—Sibutramine—obesity	0.000333	0.00285	CcSEcCtD
Molindone—Dyspnoea—Sibutramine—obesity	0.000317	0.00271	CcSEcCtD
Molindone—Dry mouth—Bupropion—obesity	0.000317	0.00271	CcSEcCtD
Molindone—Somnolence—Sibutramine—obesity	0.000317	0.00271	CcSEcCtD
Molindone—Weight increased—Topiramate—obesity	0.000317	0.00271	CcSEcCtD
Molindone—Weight decreased—Topiramate—obesity	0.000315	0.00269	CcSEcCtD
Molindone—HTR2A—endocrine gland—obesity	0.000307	0.00715	CbGeAlD
Molindone—Constipation—Sibutramine—obesity	0.000305	0.0026	CcSEcCtD
Molindone—Tachycardia—Bupropion—obesity	0.000303	0.00259	CcSEcCtD
Molindone—Hypotension—Bupropion—obesity	0.00029	0.00248	CcSEcCtD
Molindone—Dyspnoea—Bupropion—obesity	0.000277	0.00237	CcSEcCtD
Molindone—HTR2A—liver—obesity	0.000277	0.00645	CbGeAlD
Molindone—Somnolence—Bupropion—obesity	0.000276	0.00236	CcSEcCtD
Molindone—Constipation—Bupropion—obesity	0.000265	0.00227	CcSEcCtD
Molindone—Muscle spasms—Topiramate—obesity	0.000233	0.00199	CcSEcCtD
Molindone—Rash—Orlistat—obesity	0.000232	0.00198	CcSEcCtD
Molindone—Dermatitis—Orlistat—obesity	0.000232	0.00198	CcSEcCtD
Molindone—Vision blurred—Topiramate—obesity	0.000228	0.00195	CcSEcCtD
Molindone—Tremor—Topiramate—obesity	0.000227	0.00194	CcSEcCtD
Molindone—Rash—Sibutramine—obesity	0.000225	0.00192	CcSEcCtD
Molindone—Dermatitis—Sibutramine—obesity	0.000224	0.00192	CcSEcCtD
Molindone—Agitation—Topiramate—obesity	0.000223	0.0019	CcSEcCtD
Molindone—Nausea—Orlistat—obesity	0.000219	0.00187	CcSEcCtD
Molindone—Leukopenia—Topiramate—obesity	0.000217	0.00185	CcSEcCtD
Molindone—Nausea—Sibutramine—obesity	0.000212	0.00181	CcSEcCtD
Molindone—Dry mouth—Topiramate—obesity	0.000202	0.00173	CcSEcCtD
Molindone—Rash—Bupropion—obesity	0.000196	0.00167	CcSEcCtD
Molindone—Dermatitis—Bupropion—obesity	0.000196	0.00167	CcSEcCtD
Molindone—Tachycardia—Topiramate—obesity	0.000193	0.00165	CcSEcCtD
Molindone—Hypotension—Topiramate—obesity	0.000185	0.00158	CcSEcCtD
Molindone—Nausea—Bupropion—obesity	0.000184	0.00158	CcSEcCtD
Molindone—Dyspnoea—Topiramate—obesity	0.000176	0.00151	CcSEcCtD
Molindone—Somnolence—Topiramate—obesity	0.000176	0.0015	CcSEcCtD
Molindone—Constipation—Topiramate—obesity	0.000169	0.00145	CcSEcCtD
Molindone—Rash—Topiramate—obesity	0.000125	0.00107	CcSEcCtD
Molindone—Dermatitis—Topiramate—obesity	0.000125	0.00107	CcSEcCtD
Molindone—Nausea—Topiramate—obesity	0.000117	0.001	CcSEcCtD
Molindone—CHRM1—Signaling Pathways—RPS6KB1—obesity	5.23e-06	4.47e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—TYK2—obesity	5.23e-06	4.47e-05	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—PIK3CB—obesity	5.22e-06	4.46e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IGF2—obesity	5.21e-06	4.46e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—PIK3CB—obesity	5.21e-06	4.45e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—NOS3—obesity	5.2e-06	4.45e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—PIK3R1—obesity	5.2e-06	4.45e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—MTHFR—obesity	5.2e-06	4.45e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—RHOA—obesity	5.18e-06	4.44e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—PIK3CB—obesity	5.18e-06	4.43e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—GNAS—obesity	5.16e-06	4.42e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—LEP—obesity	5.15e-06	4.4e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—APOE—obesity	5.15e-06	4.4e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—PIK3R1—obesity	5.13e-06	4.39e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CAV1—obesity	5.1e-06	4.36e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PPARA—obesity	5.1e-06	4.36e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—APOA1—obesity	5.09e-06	4.35e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—APOB—obesity	5.06e-06	4.33e-05	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—PIK3CA—obesity	5.03e-06	4.3e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PRKCD—obesity	4.97e-06	4.25e-05	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—PIK3CA—obesity	4.96e-06	4.24e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—AGT—obesity	4.94e-06	4.23e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCL5—obesity	4.94e-06	4.22e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—ESR1—obesity	4.92e-06	4.21e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PRKCD—obesity	4.89e-06	4.18e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PRKCD—obesity	4.86e-06	4.16e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—HTR2A—obesity	4.86e-06	4.16e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—C3—obesity	4.86e-06	4.15e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PRKCB—obesity	4.85e-06	4.15e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—F2—obesity	4.85e-06	4.15e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—APOE—obesity	4.84e-06	4.14e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—LPL—obesity	4.83e-06	4.13e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—PIK3CB—obesity	4.8e-06	4.11e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MTOR—obesity	4.8e-06	4.11e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—BAD—obesity	4.8e-06	4.1e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—CAV1—obesity	4.79e-06	4.1e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—FOXO1—obesity	4.79e-06	4.1e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—RPS6KB1—obesity	4.78e-06	4.09e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—APOA1—obesity	4.78e-06	4.09e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—C3—obesity	4.78e-06	4.09e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—HTR2A—obesity	4.76e-06	4.07e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—C3—obesity	4.75e-06	4.07e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—PIK3CB—obesity	4.74e-06	4.05e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3CG—obesity	4.65e-06	3.98e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IRS2—obesity	4.62e-06	3.95e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—AGT—obesity	4.61e-06	3.95e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IRS1—obesity	4.59e-06	3.93e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IRS2—obesity	4.54e-06	3.89e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AGT—obesity	4.54e-06	3.88e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IRS2—obesity	4.52e-06	3.87e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—LEP—obesity	4.52e-06	3.87e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—APOE—obesity	4.52e-06	3.87e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AGT—obesity	4.51e-06	3.86e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CAV1—obesity	4.48e-06	3.83e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—APOA1—obesity	4.47e-06	3.82e-05	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—AKT1—obesity	4.46e-06	3.82e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PRKCD—obesity	4.45e-06	3.81e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—LEP—obesity	4.45e-06	3.81e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—APOE—obesity	4.45e-06	3.81e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—LEP—obesity	4.42e-06	3.78e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—APOE—obesity	4.42e-06	3.78e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—POMC—obesity	4.42e-06	3.78e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CAV1—obesity	4.41e-06	3.77e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—INS—obesity	4.4e-06	3.76e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—APOA1—obesity	4.4e-06	3.76e-05	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—IL6—obesity	4.39e-06	3.76e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CAV1—obesity	4.38e-06	3.75e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—APOA1—obesity	4.37e-06	3.74e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CG—obesity	4.37e-06	3.74e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—HTR2A—obesity	4.35e-06	3.72e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—C3—obesity	4.35e-06	3.72e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCL2—obesity	4.33e-06	3.7e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—ESR1—obesity	4.32e-06	3.69e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PRKCB—obesity	4.26e-06	3.65e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—F2—obesity	4.26e-06	3.65e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IGF1—obesity	4.25e-06	3.64e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—AKT2—obesity	4.25e-06	3.64e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—ESR1—obesity	4.25e-06	3.63e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—ESR1—obesity	4.22e-06	3.61e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PPARG—obesity	4.21e-06	3.61e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—BAD—obesity	4.21e-06	3.6e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PRKCB—obesity	4.19e-06	3.59e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—F2—obesity	4.19e-06	3.59e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MMP9—obesity	4.18e-06	3.57e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—F2—obesity	4.17e-06	3.57e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PRKCB—obesity	4.17e-06	3.57e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—POMC—obesity	4.16e-06	3.56e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—BAD—obesity	4.14e-06	3.55e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IRS2—obesity	4.13e-06	3.54e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—INS—obesity	4.13e-06	3.54e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—AGT—obesity	4.13e-06	3.53e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—BAD—obesity	4.12e-06	3.53e-05	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—AKT1—obesity	4.11e-06	3.52e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3CD—obesity	4.08e-06	3.49e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CG—obesity	4.08e-06	3.49e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MAPK8—obesity	4.06e-06	3.47e-05	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—AKT1—obesity	4.05e-06	3.47e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—LEP—obesity	4.05e-06	3.46e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—APOE—obesity	4.05e-06	3.46e-05	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—PIK3CA—obesity	4.05e-06	3.46e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—SERPINE1—obesity	4.04e-06	3.46e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IRS1—obesity	4.03e-06	3.45e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CG—obesity	4.01e-06	3.43e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CAV1—obesity	4.01e-06	3.43e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—APOA1—obesity	4e-06	3.42e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CG—obesity	3.99e-06	3.42e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IRS1—obesity	3.97e-06	3.39e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IRS1—obesity	3.95e-06	3.38e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—TYK2—obesity	3.93e-06	3.36e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—RHOA—obesity	3.9e-06	3.33e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—POMC—obesity	3.88e-06	3.32e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—ESR1—obesity	3.86e-06	3.31e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—INS—obesity	3.86e-06	3.3e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3R1—obesity	3.86e-06	3.3e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NOS3—obesity	3.86e-06	3.3e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CD—obesity	3.84e-06	3.28e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—POMC—obesity	3.82e-06	3.27e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—F2—obesity	3.82e-06	3.26e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PRKCB—obesity	3.82e-06	3.26e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—POMC—obesity	3.8e-06	3.25e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—INS—obesity	3.8e-06	3.25e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCL2—obesity	3.8e-06	3.25e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—ALB—obesity	3.79e-06	3.24e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—INS—obesity	3.78e-06	3.23e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—BAD—obesity	3.77e-06	3.23e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCL2—obesity	3.74e-06	3.2e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IGF1—obesity	3.74e-06	3.2e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—AKT2—obesity	3.73e-06	3.19e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCL2—obesity	3.72e-06	3.18e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—STAT3—obesity	3.71e-06	3.18e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IGF1—obesity	3.68e-06	3.14e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—PIK3CA—obesity	3.67e-06	3.14e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AKT2—obesity	3.67e-06	3.14e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IGF1—obesity	3.66e-06	3.13e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AKT2—obesity	3.65e-06	3.13e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CG—obesity	3.65e-06	3.12e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—NOS3—obesity	3.63e-06	3.1e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3R1—obesity	3.63e-06	3.1e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IRS1—obesity	3.61e-06	3.09e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CD—obesity	3.59e-06	3.07e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MTOR—obesity	3.56e-06	3.05e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3CB—obesity	3.56e-06	3.05e-05	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—PIK3CA—obesity	3.55e-06	3.04e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—SERPINE1—obesity	3.55e-06	3.03e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CD—obesity	3.53e-06	3.02e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CD—obesity	3.51e-06	3e-05	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—PIK3CA—obesity	3.5e-06	2.99e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—SERPINE1—obesity	3.49e-06	2.99e-05	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—PIK3CA—obesity	3.48e-06	2.97e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—POMC—obesity	3.48e-06	2.97e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—SERPINE1—obesity	3.47e-06	2.97e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—INS—obesity	3.46e-06	2.96e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MYC—obesity	3.45e-06	2.95e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—TYK2—obesity	3.45e-06	2.95e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—TGFB1—obesity	3.44e-06	2.94e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—RHOA—obesity	3.42e-06	2.93e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCL2—obesity	3.4e-06	2.91e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—TYK2—obesity	3.39e-06	2.9e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NOS3—obesity	3.39e-06	2.9e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3R1—obesity	3.39e-06	2.9e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—TYK2—obesity	3.38e-06	2.89e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—RHOA—obesity	3.37e-06	2.88e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—RHOA—obesity	3.35e-06	2.87e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CB—obesity	3.35e-06	2.86e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IGF1—obesity	3.34e-06	2.86e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—AKT2—obesity	3.34e-06	2.86e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3R1—obesity	3.33e-06	2.85e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NOS3—obesity	3.33e-06	2.85e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PTGS2—obesity	3.32e-06	2.84e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NOS3—obesity	3.31e-06	2.84e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3R1—obesity	3.31e-06	2.84e-05	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—AKT1—obesity	3.3e-06	2.83e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—IL6—obesity	3.25e-06	2.78e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—PIK3CA—obesity	3.23e-06	2.76e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CD—obesity	3.21e-06	2.75e-05	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	3.18e-06	2.72e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—SERPINE1—obesity	3.18e-06	2.72e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—PIK3CA—obesity	3.17e-06	2.72e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—PIK3CA—obesity	3.16e-06	2.7e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MTOR—obesity	3.13e-06	2.67e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CB—obesity	3.13e-06	2.67e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MMP9—obesity	3.09e-06	2.65e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TYK2—obesity	3.09e-06	2.64e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CB—obesity	3.08e-06	2.63e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MTOR—obesity	3.08e-06	2.63e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—RHOA—obesity	3.06e-06	2.62e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CB—obesity	3.06e-06	2.62e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MTOR—obesity	3.06e-06	2.62e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3R1—obesity	3.03e-06	2.59e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NOS3—obesity	3.03e-06	2.59e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MAPK8—obesity	3.01e-06	2.57e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—AKT1—obesity	3e-06	2.57e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—PIK3CA—obesity	2.93e-06	2.51e-05	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—AKT1—obesity	2.9e-06	2.48e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—PIK3CA—obesity	2.89e-06	2.47e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—IL6—obesity	2.86e-06	2.44e-05	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—AKT1—obesity	2.86e-06	2.44e-05	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—AKT1—obesity	2.84e-06	2.43e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—IL6—obesity	2.81e-06	2.4e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MTOR—obesity	2.8e-06	2.39e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CB—obesity	2.8e-06	2.39e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—IL6—obesity	2.8e-06	2.39e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—STAT3—obesity	2.75e-06	2.35e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MMP9—obesity	2.72e-06	2.32e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MMP9—obesity	2.67e-06	2.29e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MMP9—obesity	2.66e-06	2.27e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MAPK8—obesity	2.64e-06	2.26e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—AKT1—obesity	2.64e-06	2.25e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MAPK8—obesity	2.6e-06	2.22e-05	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—AKT1—obesity	2.6e-06	2.22e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—IL6—obesity	2.59e-06	2.22e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—AKT1—obesity	2.59e-06	2.22e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MAPK8—obesity	2.59e-06	2.21e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—AKT1—obesity	2.58e-06	2.21e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—IL6—obesity	2.56e-06	2.19e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MYC—obesity	2.56e-06	2.19e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—TGFB1—obesity	2.55e-06	2.18e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MMP9—obesity	2.43e-06	2.08e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—STAT3—obesity	2.42e-06	2.07e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—AKT1—obesity	2.39e-06	2.05e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—STAT3—obesity	2.38e-06	2.03e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAPK8—obesity	2.37e-06	2.02e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—STAT3—obesity	2.36e-06	2.02e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—AKT1—obesity	2.36e-06	2.02e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MYC—obesity	2.24e-06	1.92e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—TGFB1—obesity	2.24e-06	1.92e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MYC—obesity	2.21e-06	1.89e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—TGFB1—obesity	2.2e-06	1.89e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MYC—obesity	2.2e-06	1.88e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—TGFB1—obesity	2.19e-06	1.87e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3CA—obesity	2.17e-06	1.86e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—STAT3—obesity	2.16e-06	1.85e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CA—obesity	2.04e-06	1.75e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MYC—obesity	2.01e-06	1.72e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TGFB1—obesity	2e-06	1.71e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL6—obesity	1.92e-06	1.64e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CA—obesity	1.91e-06	1.63e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CA—obesity	1.87e-06	1.6e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CA—obesity	1.86e-06	1.6e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—AKT1—obesity	1.77e-06	1.52e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CA—obesity	1.71e-06	1.46e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL6—obesity	1.69e-06	1.44e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—AKT1—obesity	1.67e-06	1.43e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL6—obesity	1.66e-06	1.42e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL6—obesity	1.65e-06	1.41e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—AKT1—obesity	1.56e-06	1.33e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AKT1—obesity	1.53e-06	1.31e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AKT1—obesity	1.52e-06	1.3e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL6—obesity	1.51e-06	1.29e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—AKT1—obesity	1.39e-06	1.19e-05	CbGpPWpGaD
